4.99
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Titan Pharmaceuticals Inc De Azioni (TTNP) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
Revenues |
-
|
- | - | - | - |
Operating Expenses |
23.03%
0.657
|
0.534 | 0.666 | 0.754 | 2.074 |
Operating Income/Loss |
23.03%
-0.657
|
-0.534 | -0.666 | -0.754 | -2.074 |
Nonoperating Income/Loss |
10.34%
-0.032
|
-0.029 | -0.124 | -0.009 | -0.019 |
Income/Loss From Continuing Operations Before Tax |
22.38%
-0.689
|
-0.563 | -0.789 | -0.763 | -2.093 |
Income/Loss From Continuing Operations After Tax |
22.38%
-0.689
|
-0.563 | -0.79 | -0.763 | -2.093 |
|
22.38%
-0.689
|
-0.563 | -0.79 | -0.763 | -2.093 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
16.52%
1.065
|
0.914 | 0.005 | 0.914 | 0.914 |
Diluted Average Shares |
16.52%
1.065
|
0.914 | 0.005 | 0.914 | 0.914 |
Basic Earnings Per Share |
4.84%
-0.65
|
-0.62 | -0.85 | -0.83 | -2.29 |
Diluted Earnings Per Share |
4.84%
-0.65
|
-0.62 | -0.85 | -0.83 | -2.29 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):